DE2711950A1 - Neue lactone, die sich vom cyclopentanol herleiten, deren herstellungsverfahren und diese enthaltende pharmazeutische zusammensetzungen - Google Patents

Neue lactone, die sich vom cyclopentanol herleiten, deren herstellungsverfahren und diese enthaltende pharmazeutische zusammensetzungen

Info

Publication number
DE2711950A1
DE2711950A1 DE19772711950 DE2711950A DE2711950A1 DE 2711950 A1 DE2711950 A1 DE 2711950A1 DE 19772711950 DE19772711950 DE 19772711950 DE 2711950 A DE2711950 A DE 2711950A DE 2711950 A1 DE2711950 A1 DE 2711950A1
Authority
DE
Germany
Prior art keywords
radical
formula
products
product
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE19772711950
Other languages
German (de)
English (en)
Inventor
Jean Buendia
Michel Vivat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of DE2711950A1 publication Critical patent/DE2711950A1/de
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Epoxy Compounds (AREA)
DE19772711950 1976-03-19 1977-03-18 Neue lactone, die sich vom cyclopentanol herleiten, deren herstellungsverfahren und diese enthaltende pharmazeutische zusammensetzungen Ceased DE2711950A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7608004A FR2344285A1 (fr) 1976-03-19 1976-03-19 Nouvelles lactones derivees du cyclopentanol, leur procede de preparation et leur application comme medicaments

Publications (1)

Publication Number Publication Date
DE2711950A1 true DE2711950A1 (de) 1977-09-29

Family

ID=9170682

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19772711950 Ceased DE2711950A1 (de) 1976-03-19 1977-03-18 Neue lactone, die sich vom cyclopentanol herleiten, deren herstellungsverfahren und diese enthaltende pharmazeutische zusammensetzungen

Country Status (20)

Country Link
JP (1) JPS52113956A (xx)
AT (1) AT357275B (xx)
AU (1) AU506760B2 (xx)
BE (1) BE852624A (xx)
CA (1) CA1094569A (xx)
CH (1) CH620688A5 (xx)
DE (1) DE2711950A1 (xx)
DK (1) DK119377A (xx)
ES (1) ES456999A1 (xx)
FR (1) FR2344285A1 (xx)
GB (1) GB1538717A (xx)
HU (1) HU178332B (xx)
IE (1) IE45124B1 (xx)
IL (1) IL51690A (xx)
LU (1) LU76976A1 (xx)
NL (1) NL7703056A (xx)
PT (1) PT66326B (xx)
SE (1) SE436877B (xx)
SU (2) SU749364A3 (xx)
ZA (1) ZA771654B (xx)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2949003A1 (de) * 1978-12-05 1980-06-19 Roussel Uclaf Neue beta -lactone der 2-hydroxycyclopentancarbonsaeure, ihr herstellungsverfahren, ihre verwendung als arzneimittel und die sie enthaltenden pharmazeutischen zusammensetzungen
EP0298300A1 (de) * 1987-07-04 1989-01-11 Bayer Ag Azolyl-tetrahydropyran-Derivate

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2439779A2 (fr) * 1976-03-19 1980-05-23 Roussel Uclaf Nouvelles lactones derivees du cyclopentanol, leur procede de preparation et leur application comme medicaments
EP1142886A1 (en) * 2000-04-07 2001-10-10 Aventis Pharma Deutschland GmbH Percyquinnin, a process for its production and its use as a pharmaceutical
CN100417650C (zh) * 2006-08-17 2008-09-10 中国科学院昆明植物研究所 韧革菌素及其制备方法和在药物上的应用
CN102498105B (zh) * 2009-07-28 2014-04-02 小野药品工业株式会社 双环化合物及其医疗用途

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NICHTS-ERMITTELT *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2949003A1 (de) * 1978-12-05 1980-06-19 Roussel Uclaf Neue beta -lactone der 2-hydroxycyclopentancarbonsaeure, ihr herstellungsverfahren, ihre verwendung als arzneimittel und die sie enthaltenden pharmazeutischen zusammensetzungen
EP0298300A1 (de) * 1987-07-04 1989-01-11 Bayer Ag Azolyl-tetrahydropyran-Derivate
US4888048A (en) * 1987-07-04 1989-12-19 Bayer Aktiengesellschaft Fungicidal and plant growth-regulating azolyl-tetrahydropyran derivatives

Also Published As

Publication number Publication date
DK119377A (da) 1977-09-20
PT66326A (fr) 1977-04-01
CA1094569A (fr) 1981-01-27
SE436877B (sv) 1985-01-28
AT357275B (de) 1980-06-25
AU2346677A (en) 1978-09-28
IL51690A0 (en) 1977-05-31
LU76976A1 (xx) 1977-10-03
ES456999A1 (es) 1978-01-16
SE7702908L (sv) 1977-09-20
HU178332B (en) 1982-04-28
AU506760B2 (en) 1980-01-24
ZA771654B (en) 1978-04-26
IE45124L (en) 1977-09-19
SU749364A3 (ru) 1980-07-15
PT66326B (pt) 1979-01-18
NL7703056A (nl) 1977-09-21
FR2344285B1 (xx) 1979-02-02
GB1538717A (en) 1979-01-24
CH620688A5 (en) 1980-12-15
JPS52113956A (en) 1977-09-24
JPS62146B2 (xx) 1987-01-06
FR2344285A1 (fr) 1977-10-14
BE852624A (fr) 1977-09-19
IL51690A (en) 1982-02-28
ATA195077A (de) 1979-11-15
SU745366A3 (ru) 1980-06-30
IE45124B1 (en) 1982-06-30

Similar Documents

Publication Publication Date Title
EP0185359B1 (de) Oxetanone
DE69215070T2 (de) Verfahren zur herstellung von 3-dpa-lacton
DE2416193C2 (de) Prostaglandin-Analoge, Verfahren zu ihrer Herstellung sowie ihre Verwendung als cytoprotektives Mittel
DE2627704C2 (de) Bicycloheptenverbindungen, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2714129A1 (de) Prostaglandinderivate, verfahren zu deren herstellung und deren verwendung
DE2234709C2 (de) Prostanoesäurederivate und Verfahren zu deren Herstellung
DE2711950A1 (de) Neue lactone, die sich vom cyclopentanol herleiten, deren herstellungsverfahren und diese enthaltende pharmazeutische zusammensetzungen
DE3153427C2 (xx)
CH643838A5 (de) 15-epi-prostacyclinderivate, verfahren zu ihrer herstellung und pharmazeutische praeparate.
CH640847A5 (en) Process for preparing analogues of 5,6-dihydroprostacyclin
DE2347172A1 (de) Prostaglandin e tief 1-synthese
DE2949003C2 (xx)
DE2847049A1 (de) 13,14-didehydro-prostaglandine, verfahren zu ihrer herstellung und sie enthaltendes pharmazeutisches oder veterinaermedizinisches mittel
DE2715921A1 (de) Neue zwischenprodukte und verfahren zur herstellung von thromboxan b tief 2
AT371814B (de) Verfahren zur herstellung von neuen lactonderivaten des cyclopentanols
DE2306580C2 (de) Verfahren zur Herstellung von 16-Acylderivaten des Gitoxigenindigitoxosids
DE2640692C3 (de) Optisch aktive 5- (2-Carboxythiophen5-yl)-16phenoxy- a -tetranor- w tetranor-prostaglandine
DE1593644C3 (xx)
DE2246867A1 (de) Tetrahydroxy-bicyclo- eckige klammer auf 3.3.0 eckige klammer zu -octane
DE2739770C3 (de) 19-Methyl-9-keto-15-hydroxy-prost-18-ensäure-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
CH449006A (de) Verfahren zur Herstellung von Fusidinsäure- und Dihydrofusidinsäurederivaten
DE3028776A1 (de) Neue 1,3-diphenoxypropan-2-on-derivate sowie verfahren zu ihrer herstellung und diese enthaltende arzneimittel
EP0818447B1 (de) 6-(Hydroxymethyl-ethyl)pyridine als HMG-CoA-Reduktase Inhibitoren
DE1264441B (de) Verfahren zur Herstellung von 17alpha-AEthinyl-delta 5(10-19-nor-androsten-17beta-ol-3-on und 17alpha-AEthynil-19-nor-testosteron sowie dessen Estern
DE1966921C3 (de) 17 alpha-propadienylsubstituierte 3-Ketosteroide und Verfahren zu deren Herstellung

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8128 New person/name/address of the agent

Representative=s name: ZUMSTEIN SEN., F., DR. ASSMANN, E., DIPL.-CHEM. DR

8131 Rejection